 |
New anti-clotting drugs jostle for market shareNew drugs to prevent dangerous blood clots promise to shake up the market but pharmaceutical companies face an uphill fight on price. Cost will be key for both AstraZeneca's Brilinta and Boehringer Ingelheim's Pradaxa as they jostle for sa More… |
Friday 26 April 2024
